Panbela Therapeutics, Inc. (PBLA)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 11, 2026, 4:00 PM EST
Panbela Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -27.91 | -25.26 | -34.93 | -10.14 | -4.77 | -6.2 |
Other Amortization | - | - | - | - | - | 2.08 |
Loss (Gain) From Sale of Assets | -0.78 | -0.4 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | - | 17.74 | - | - | - |
Stock-Based Compensation | 0.23 | 0.82 | 1.09 | 1.29 | 1.21 | 1.09 |
Other Operating Activities | 0.59 | 0.24 | 0.27 | - | -0.1 | 0.1 |
Change in Accounts Payable | 3.49 | 7.06 | 2.25 | 0.63 | -0.75 | 0.3 |
Change in Income Taxes | -0.16 | -0.13 | 0.21 | 0.05 | -0 | -0.03 |
Change in Other Net Operating Assets | 8.97 | -7.58 | -1.9 | 0.92 | 0.56 | -0.08 |
Operating Cash Flow | -15.57 | -25.25 | -15.28 | -7.25 | -3.85 | -2.74 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Cash Acquisitions | - | - | 0 | - | - | - |
Sale (Purchase) of Intangibles | 0.78 | 0.4 | -0.66 | - | - | - |
Investing Cash Flow | 0.78 | 0.4 | -0.66 | - | - | - |
Short-Term Debt Issued | - | - | - | - | 0.1 | - |
Long-Term Debt Issued | - | - | - | - | - | 0.82 |
Total Debt Issued | 2.2 | - | - | - | 0.1 | 0.82 |
Short-Term Debt Repaid | - | -1.65 | - | - | -0.74 | -0.03 |
Long-Term Debt Repaid | - | - | - | - | -0.12 | -0.16 |
Total Debt Repaid | -1 | -1.65 | - | - | -0.86 | -0.19 |
Net Debt Issued (Repaid) | 1.2 | -1.65 | - | - | -0.76 | 0.63 |
Issuance of Common Stock | 13.76 | 29.93 | 6.13 | 11.04 | 12.37 | 3.18 |
Repurchase of Common Stock | -0 | -0.01 | - | - | - | - |
Other Financing Activities | -0.92 | -2.12 | -0.77 | -0.95 | -1.17 | -0.02 |
Financing Cash Flow | 14.03 | 26.14 | 5.35 | 10.1 | 10.44 | 3.78 |
Foreign Exchange Rate Adjustments | 0 | - | -0 | -0.01 | -0.02 | -0 |
Net Cash Flow | -0.77 | 1.29 | -10.58 | 2.85 | 6.57 | 1.04 |
Free Cash Flow | -15.57 | -25.25 | -15.28 | -7.25 | -3.85 | -2.74 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -4.75 | -232.30 | - | - | - | - |
Levered Free Cash Flow | -7.98 | -9.86 | -6.53 | -3.36 | -2.03 | -1.48 |
Unlevered Free Cash Flow | -7.58 | -9.66 | -6.35 | -3.35 | -2.02 | -2.19 |
Cash Interest Paid | 0.29 | 0.4 | 0.02 | 0.01 | 0.01 | 0.01 |
Change in Working Capital | 12.3 | -0.65 | 0.56 | 1.6 | -0.19 | 0.19 |